Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both ...

The Business Group on Health is paying attention to Medicaid cuts, tariffs, threats to ERISA and more. There is no shortage ...

Healthcare leaders are continuing to express their concerns about the changes that President Donald Trump’s administration is making to HHS. Just this week, 20 state attorneys general sued the ...

Americans are facing difficult times, including rising healthcare costs and increasing prevalence of mental health challenges. And many are looking to their employer for support. That’s why ...

For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s ...

Bringing a new drug to market is staggeringly inefficient: About 90% of new drugs fail in clinical trials, development times are 10-15 years, and the costs can run in excess of $2 billion dollars.

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.

Analyzing medical claims data is essential to fulfilling a self-funded employer’s fiduciary duty, which is to get the best medical benefits for the best price for their employees. However, many ...